JANX logo

Janux Therapeutics, Inc. (JANX) Selling, general & administrative expenses

annual SGA:

$41.05M+$14.91M(+57.03%)
December 31, 2024

Summary

  • As of today (September 15, 2025), JANX annual SGA is $41.05 million, with the most recent change of +$14.91 million (+57.03%) on December 31, 2024.
  • During the last 3 years, JANX annual SGA has risen by +$30.72 million (+297.40%).
  • JANX annual SGA is now at all-time high.

Performance

JANX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXincome statement metrics

quarterly SGA:

$10.45M+$612.00K(+6.22%)
June 30, 2025

Summary

  • As of today (September 15, 2025), JANX quarterly SGA is $10.45 million, with the most recent change of +$612.00 thousand (+6.22%) on June 30, 2025.
  • Over the past year, JANX quarterly SGA has increased by +$2.63 million (+33.67%).
  • JANX quarterly SGA is now -40.83% below its all-time high of $17.67 million, reached on September 30, 2024.

Performance

JANX quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXincome statement metrics

TTM SGA:

-$1.01B-$105.64M(-11.66%)
June 30, 2025

Summary

  • As of today (September 15, 2025), JANX TTM SGA is -$1.01 billion, with the most recent change of -$105.64 million (-11.66%) on June 30, 2025.
  • Over the past year, JANX TTM SGA has dropped by -$1.04 billion (-3718.46%).
  • JANX TTM SGA is now -6764.01% below its all-time high of -$14.74 million.

Performance

JANX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

JANX Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+57.0%+33.7%-3718.5%
3 y3 years+297.4%+88.7%-5695.6%
5 y5 years+5217.0%+2314.3%-10000.0%

JANX Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+297.4%-40.8%+88.7%-360.0%at low
5 y5-yearat high+5217.0%-40.8%+2377.3%-6764.0%at low
alltimeall timeat high+5217.0%-40.8%+3674.0%-6764.0%at low

JANX Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$10.45M(+6.2%)
$46.18M(+6.0%)
Mar 2025
-
$9.84M(+19.8%)
$43.55M(+6.1%)
Dec 2024
$41.05M(+57.0%)
$8.22M(-53.5%)
$41.05M(+4.7%)
Sep 2024
-
$17.67M(+125.9%)
$39.19M(+40.2%)
Jun 2024
-
$7.82M(+6.5%)
$27.96M(+3.5%)
Mar 2024
-
$7.34M(+15.5%)
$27.02M(+3.4%)
Dec 2023
$26.14M(+17.4%)
$6.36M(-1.3%)
$26.14M(+2.7%)
Sep 2023
-
$6.44M(-6.4%)
$25.46M(+1.4%)
Jun 2023
-
$6.88M(+6.5%)
$25.12M(+5.6%)
Mar 2023
-
$6.46M(+13.9%)
$23.78M(+6.8%)
Dec 2022
$22.26M
$5.68M(-6.9%)
$22.26M(+8.5%)
DateAnnualQuarterlyTTM
Sep 2022
-
$6.10M(+10.1%)
$20.52M(+13.5%)
Jun 2022
-
$5.54M(+12.0%)
$18.08M(+24.4%)
Mar 2022
-
$4.95M(+25.7%)
$14.54M(+40.7%)
Dec 2021
$10.33M(+473.2%)
$3.94M(+7.7%)
$10.33M(+46.3%)
Sep 2021
-
$3.66M(+83.1%)
$7.06M(+84.5%)
Jun 2021
-
$2.00M(+170.2%)
$3.83M(+69.1%)
Mar 2021
-
$739.00K(+10.3%)
$2.26M(+25.6%)
Dec 2020
$1.80M(+133.4%)
$670.00K(+58.8%)
$1.80M(+59.2%)
Sep 2020
-
$422.00K(-2.5%)
$1.13M(+59.4%)
Jun 2020
-
$433.00K(+56.3%)
$710.00K(+156.3%)
Mar 2020
-
$277.00K
$277.00K
Dec 2019
$772.00K
-
-

FAQ

  • What is Janux Therapeutics, Inc. annual SGA?
  • What is the all time high annual SGA for Janux Therapeutics, Inc.?
  • What is Janux Therapeutics, Inc. annual SGA year-on-year change?
  • What is Janux Therapeutics, Inc. quarterly SGA?
  • What is the all time high quarterly SGA for Janux Therapeutics, Inc.?
  • What is Janux Therapeutics, Inc. quarterly SGA year-on-year change?
  • What is Janux Therapeutics, Inc. TTM SGA?
  • What is the all time high TTM SGA for Janux Therapeutics, Inc.?
  • What is Janux Therapeutics, Inc. TTM SGA year-on-year change?

What is Janux Therapeutics, Inc. annual SGA?

The current annual SGA of JANX is $41.05M

What is the all time high annual SGA for Janux Therapeutics, Inc.?

Janux Therapeutics, Inc. all-time high annual SGA is $41.05M

What is Janux Therapeutics, Inc. annual SGA year-on-year change?

Over the past year, JANX annual SGA has changed by +$14.91M (+57.03%)

What is Janux Therapeutics, Inc. quarterly SGA?

The current quarterly SGA of JANX is $10.45M

What is the all time high quarterly SGA for Janux Therapeutics, Inc.?

Janux Therapeutics, Inc. all-time high quarterly SGA is $17.67M

What is Janux Therapeutics, Inc. quarterly SGA year-on-year change?

Over the past year, JANX quarterly SGA has changed by +$2.63M (+33.67%)

What is Janux Therapeutics, Inc. TTM SGA?

The current TTM SGA of JANX is -$1.01B

What is the all time high TTM SGA for Janux Therapeutics, Inc.?

Janux Therapeutics, Inc. all-time high TTM SGA is -$14.74M

What is Janux Therapeutics, Inc. TTM SGA year-on-year change?

Over the past year, JANX TTM SGA has changed by -$1.04B (-3718.46%)
On this page